0,643  0,031  Caspase 9 stimulant
0,617  0,010  Antiprotozoal (Plasmodium)
0,603  0,003  Topoisomerase I inhibitor
0,638  0,042  Apoptosis agonist
0,594  0,005  Antidiabetic symptomatic
0,600  0,019  Aldehyde oxidase inhibitor
0,587  0,009  UGT1A6 substrate
0,584  0,013  UGT1A9 substrate
0,576  0,022  Antiprotozoal
0,576  0,023  Antibacterial
0,563  0,016  Antineoplastic (melanoma)
0,529  0,004  Antineoplastic antibiotic
0,532  0,019  CTGF expression inhibitor
0,523  0,028  Prostate cancer treatment
0,535  0,045  Antiarthritic
0,510  0,021  Ulceration
0,504  0,032  Teratogen
0,469  0,004  Cystathionine beta-synthase inhibitor
0,478  0,021  NOS2 expression inhibitor
0,480  0,024  Sensitization
0,467  0,015  Antihypertriglyceridemic
0,483  0,031  GABA C receptor rho-3 antagonist
0,446  0,004  HIV-1 integrase (3'-Processing) inhibitor
0,488  0,050  TNF expression inhibitor
0,465  0,028  FMO1 substrate
0,443  0,008  Topoisomerase II inhibitor
0,458  0,026  NOS3 expression inhibitor
0,465  0,034  Embryotoxic
0,474  0,045  Antileukemic
0,432  0,014  Antimutagenic
0,425  0,007  UGT2B15 substrate
0,438  0,033  CYP1A2 substrate
0,411  0,014  UGT1A4 substrate
0,398  0,005  Topoisomerase II alpha inhibitor
0,442  0,055  Antineoplastic (lung cancer)
0,394  0,018  UGT1A1 substrate
0,432  0,057  Transcription factor NF kappa B inhibitor
0,378  0,011  Pneumotoxic
0,402  0,035  Antioxidant
0,433  0,070  Antineoplastic (breast cancer)
0,365  0,005  SULT1A3 substrate
0,391  0,031  Cardiovascular analeptic
0,370  0,012  Genotoxic
0,370  0,014  UGT1A3 substrate
0,389  0,034  CYP1A2 inhibitor
0,388  0,034  UGT2B4 substrate
0,361  0,011  Acaricide
0,403  0,053  Antineoplastic (colorectal cancer)
0,362  0,016  Antiseptic
0,394  0,051  Antineoplastic (colon cancer)
0,384  0,044  12-Lipoxygenase inhibitor
0,371  0,035  Carcinogenic
0,375  0,039  Chemoprotective
0,386  0,051  Streptokinase A inhibitor
0,346  0,013  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,349  0,016  Melanin inhibitor
0,350  0,021  Antiviral (HIV)
0,346  0,024  RNA-directed DNA polymerase inhibitor
0,363  0,042  Calcium channel activator
0,370  0,053  Caspase 3 stimulant
0,346  0,029  Peroxidase inhibitor
0,343  0,028  5 Hydroxytryptamine uptake stimulant
0,365  0,051  AR expression inhibitor
0,319  0,005  Telomerase inhibitor
0,368  0,055  Antifungal
0,344  0,035  Antineoplastic (liver cancer)
0,320  0,016  Monophenol monooxygenase inhibitor
0,325  0,022  UGT2B7 substrate
0,341  0,041  Free radical scavenger
0,303  0,005  SULT1A1 substrate
0,358  0,061  Cholesterol antagonist
0,314  0,019  Skin whitener
0,337  0,049  Hypoxia-inducible factor 1 alpha inhibitor
0,303  0,017  Neurotrophic factor enhancer
0,362  0,076  CYP2C9 substrate
0,317  0,032  UDP-glucuronosyltransferase substrate
0,331  0,046  Antineoplastic (small cell lung cancer)
0,324  0,041  Mutagenic
0,300  0,021  Carcinogenic, group 3
0,299  0,022  Antineoplastic (squamous cell carcinoma)
0,297  0,024  Systemic lupus erythematosus treatment
0,356  0,084  GST A substrate
0,322  0,052  Antineoplastic (cervical cancer)
0,310  0,041  GST M1-1 substrate
0,332  0,063  Antimycobacterial
0,307  0,039  Nitric oxide antagonist
0,370  0,103  Calcium channel L-type activator
0,305  0,042  DNA synthesis inhibitor
0,303  0,040  Antineoplastic (sarcoma)
0,271  0,015  UGT2B9 substrate
0,265  0,013  Cell adhesion inhibitor
0,255  0,005  Electron transport complex I inhibitor
0,293  0,043  Chemopreventive
0,286  0,040  Tyrosine 3 hydroxylase inhibitor
0,282  0,037  Antihypotensive
0,290  0,046  Antiparasitic
0,301  0,057  Antineoplastic (glioma)
0,266  0,023  Protein kinase stimulant
0,308  0,072  Respiratory analeptic
0,299  0,067  CYP2C19 substrate
0,236  0,009  Coagulant
0,237  0,011  Antirickettsial
0,292  0,067  Glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase inhibitor
0,277  0,054  Antineoplastic (glioblastoma multiforme)
0,295  0,073  Lipoxygenase inhibitor
0,291  0,070  Radioprotector
0,242  0,022  Acetylcholinesterase inhibitor
0,237  0,017  UGT2B10 substrate
0,289  0,071  FMO3 substrate
0,296  0,083  Sodium/bile acid cotransporter inhibitor
0,327  0,113  15-Lipoxygenase inhibitor
0,228  0,016  Antihemorrhagic
0,268  0,060  Cytostatic
0,225  0,020  5-Lipoxygenase inhibitor
0,284  0,079  Antineoplastic (ovarian cancer)
0,238  0,033  Contraceptive
0,268  0,064  Antineoplastic (bladder cancer)
0,251  0,047  Abortion inducer
0,210  0,009  NAD(P)H dehydrogenase (quinone) inhibitor
0,312  0,113  Antipruritic, allergic
0,208  0,009  Creatine kinase inhibitor
0,205  0,009  Cell adhesion molecule inhibitor
0,243  0,047  Antihelmintic
0,255  0,060  Pyruvate kinase inhibitor
0,255  0,060  Cytotoxic
0,238  0,047  Hepatoprotectant
0,210  0,019  Carcinogenic, group 2B
0,261  0,070  Hypoglycemic
0,224  0,034  Interferon gamma antagonist
0,256  0,067  Angiogenesis stimulant
0,222  0,034  Succinate dehydrogenase inhibitor
0,269  0,082  Antihypoxic
0,213  0,027  Antifungal enhancer
0,275  0,091  Analeptic
0,199  0,016  UGT2B1 substrate
0,215  0,036  VEGF expression inhibitor
0,221  0,044  Eye irritation, high
0,250  0,076  Proliferative diseases treatment
0,318  0,145  5 Hydroxytryptamine release inhibitor
0,191  0,018  Sulfotransferase substrate
0,178  0,005  HIV-1 integrase inhibitor
0,179  0,007  Ca2+-transporting ATPase inhibitor
0,250  0,079  Antihypercholesterolemic
0,281  0,111  CYP3A4 substrate
0,201  0,032  Arachidonic acid antagonist
0,294  0,126  Histamine release inhibitor
0,273  0,107  ICAM1 expression inhibitor
0,176  0,014  Actinic keratosis treatment
0,203  0,043  Antineoplastic (carcinoma)
0,188  0,029  DNA intercalator
0,196  0,038  Tubulin antagonist
0,222  0,066  VCAM1 expression inhibitor
0,204  0,049  Antihelmintic (Nematodes)
0,198  0,045  Amylase inhibitor
0,208  0,056  Antipruritic, non-allergic
0,248  0,098  Cardioprotectant
0,160  0,009  Vanilloid agonist
0,178  0,032  Glutathione S-transferase substrate
0,194  0,049  Cholinergic
0,156  0,012  CDC25A inhibitor
0,179  0,035  Toll-Like receptor 2 antagonist
0,213  0,070  Nitric-oxide synthase stimulant
0,206  0,063  CYP2B6 inhibitor
0,162  0,019  Estrogen antagonist
0,324  0,182  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,175  0,035  Aldehyde dehydrogenase inhibitor
0,163  0,023  TRPA1 agonist
0,253  0,114  Antineoplastic (osteosarcoma)
0,177  0,039  Skin irritative effect
0,175  0,041  CF transmembrane conductance regulator agonist
0,150  0,018  Anabolic
0,191  0,060  Dual specificity phosphatase inhibitor
0,147  0,016  Estrogen receptor beta antagonist
0,146  0,017  UGT2B11 substrate
0,228  0,099  Flavin-containing monooxygenase substrate
0,183  0,054  ATPase inhibitor
0,183  0,055  Phobic disorders treatment
0,157  0,032  Vanilloid 1 agonist
0,150  0,025  HIV-1 integrase (Overall Integration) inhibitor
0,142  0,018  SULT1E1 substrate
0,175  0,053  Lipid peroxidase inhibitor
0,131  0,010  SULT1A2 substrate
0,164  0,043  Adenylate cyclase stimulant
0,170  0,049  Mannose-6-phosphate isomerase inhibitor
0,144  0,024  Antispirochetal
0,135  0,014  HIV-1 integrase (Strand Transfer) inhibitor
0,158  0,041  Cholesterol synthesis inhibitor
0,224  0,107  Transcription factor STAT3 inhibitor
0,142  0,026  Prolactin inhibitor
0,127  0,013  GABA aminotransferase inhibitor
0,142  0,028  Antifungal (Pneumocystis)
0,138  0,029  DOPA decarboxylase inhibitor
0,116  0,008  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,166  0,061  Hexokinase inhibitor
0,156  0,051  Antifungal (Cryptococcus)
0,164  0,061  Heat shock protein 90 antagonist
0,123  0,020  Keratolytic
0,127  0,025  Antibiotic
0,195  0,093  Cardiodepressant
0,138  0,038  Antiviral (Influenza B)
0,134  0,034  Beta glucuronidase inhibitor
0,154  0,054  MAP kinase kinase 4 inhibitor
0,160  0,061  GABA C receptor rho-2 antagonist
0,169  0,070  Heat shock protein 90 alpha antagonist
0,118  0,019  Estrogen receptor alpha antagonist
0,141  0,044  Antineoplastic (uterine cancer)
0,139  0,043  Contraceptive female
0,120  0,026  Antiviral (Trachoma)
0,107  0,015  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,160  0,069  Protein-tyrosine phosphatase inhibitor
0,205  0,116  Interleukin agonist
0,119  0,031  Thioredoxin inhibitor
0,131  0,045  Photosensitizer
0,106  0,020  Aromatase inhibitor
0,104  0,020  Estrogen-related receptor beta agonist
0,100  0,016  CDC25B inhibitor
0,224  0,140  Antineoplastic (brain cancer)
0,127  0,045  Antihelmintic (Fasciola)
0,139  0,058  Antihelmintic (Trematoda)
0,185  0,107  Antiglaucomic
0,124  0,046  Xanthine oxidase inhibitor
0,193  0,115  Antineoplastic (renal cancer)
0,152  0,074  Aldose reductase substrate
0,135  0,058  DNA polymerase I inhibitor
0,197  0,120  Superoxide dismutase inhibitor
0,092  0,016  Antimycoplasmal
0,102  0,027  Thioredoxin reductase inhibitor
0,209  0,135  Gastrin inhibitor
0,127  0,053  Microtubule formation inhibitor
0,190  0,116  Antipyretic
0,204  0,132  Transcription factor STAT inhibitor
0,192  0,122  DNA damaging
0,128  0,059  Sphingosine 1-phosphate receptor 4 antagonist
0,117  0,049  Antiprotozoal (Toxoplasma)
0,158  0,091  Phospholipase C inhibitor
0,186  0,119  Peptidyltransferase inhibitor
0,087  0,021  Neuraminidase inhibitor
0,085  0,019  SULT2A1 substrate
0,079  0,014  Postcoital contraceptive
0,091  0,025  Beta tubulin antagonist
0,102  0,037  Transcription factor NF kappa B stimulant
0,069  0,005  Protein 30S ribosomal subunit inhibitor
0,133  0,068  NADPH oxidase inhibitor
0,203  0,139  CYP2D6 substrate
0,098  0,037  Porphobilinogen synthase inhibitor
0,080  0,021  Heat shock protein 90 beta antagonist
0,073  0,015  Estrogen receptor beta agonist
0,127  0,070  Cyclooxygenase 3 inhibitor
0,076  0,019  Heme oxygenase stimulant
0,188  0,132  5 Hydroxytryptamine release stimulant
0,079  0,023  Postmenopausal disorders treatment
0,158  0,102  Amyloid beta aggregation inhibitor
0,101  0,046  Triose-phosphate isomerase inhibitor
0,138  0,083  Heat shock protein 70 antagonist
0,086  0,032  Glycine receptor agonist
0,069  0,016  Estradiol 17 beta-dehydrogenase inhibitor
0,135  0,084  Antiprotozoal (Coccidial)
0,154  0,103  Wound healing agent
0,099  0,048  Androgen antagonist
0,073  0,023  Alpha tubulin antagonist
0,143  0,095  Uterine stimulant
0,090  0,041  Na+ K+ transporting ATPase inhibitor
0,143  0,095  Carcinogenic, group 1
0,098  0,050  Antithrombocytopenic
0,060  0,012  Dopamine D5 agonist
0,119  0,071  M18 aspartyl aminopeptidase inhibitor
0,096  0,049  Ornithine decarboxylase inhibitor
0,156  0,108  P-glycoprotein inhibitor
0,104  0,058  Carbonic anhydrase III inhibitor
0,110  0,064  GABA C receptor antagonist
0,065  0,020  Pregnane X receptor antagonist
0,052  0,007  ATP citrate lysase inhibitor
0,084  0,041  Narcotic antagonist
0,063  0,020  Topoisomerase II beta inhibitor
0,102  0,059  UDP-glucose 4-epimerase inhibitor
0,092  0,052  ATPase (Vacuolar H+) inhibitor
0,067  0,027  Estrogen agonist
0,088  0,048  D-Ala-D-Ala ligase inhibitor
0,118  0,080  Gastritis treatment
0,102  0,064  Carbonic anhydrase XV inhibitor
0,074  0,036  Glutamate (mGluR7) antagonist
0,091  0,055  Antidote, mercury
0,150  0,115  Antineoplastic (bone cancer)
0,153  0,118  Antimitotic
0,068  0,033  Transcription factor RelA inhibitor
0,106  0,073  Protein-tyrosine phosphatase 1B inhibitor
0,130  0,097  NOS3 expression enhancer
0,092  0,060  GST P1-1 substrate
0,123  0,091  Antianorexic
0,166  0,134  Antineoplastic (non-small cell lung cancer)
0,040  0,009  Estradiol 17 beta-dehydrogenase 1 inhibitor
0,078  0,046  Glutamate decarboxylase inhibitor
0,087  0,056  Carcinogenic, group 2A
0,036  0,005  Vanilloid 2 agonist
0,185  0,155  Radiosensitizer
0,109  0,079  Alkylator
0,093  0,065  Bile acid receptor antagonist
0,155  0,127  Insulin sensitizer
0,045  0,018  Estradiol 17 beta-dehydrogenase 2 inhibitor
0,076  0,049  NAT1 substrate
0,064  0,039  TRPA1 antagonist
0,112  0,086  Alpha-N-acetylglucosaminidase inhibitor
0,026  0,003  Antibiotic Tetracycline-like
0,119  0,096  Neurotrophic factor
0,182  0,159  Antiviral (West Nile virus)
0,067  0,045  Glutamate (mGluR6) antagonist
0,141  0,119  Lipocortins synthesis antagonist
0,144  0,123  Non-steroidal antiinflammatory agent
0,074  0,052  Glutamate dehydrogenase inhibitor
0,123  0,102  Antidote
0,134  0,113  Movement disorders treatment
0,224  0,203  CYP2C19 inhibitor
0,046  0,026  Guanylate cyclase inhibitor
0,125  0,105  Thrombolytic
0,056  0,036  Dihydroorotate oxidase inhibitor
0,088  0,069  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,024  0,005  Antibiotic Anthracycline-like
0,048  0,030  Adenylate cyclase 1 inhibitor
0,076  0,059  MAP kinase kinase 7 inhibitor
0,084  0,067  NADH dehydrogenase inhibitor
0,096  0,079  Choleretic
0,056  0,041  Fatty acid synthase inhibitor
0,072  0,058  Vanilloid 4 agonist
0,109  0,095  Antihyperlipoproteinemic
0,075  0,061  Interferon agonist
0,038  0,025  5-Alpha-reductase inhibitor
0,090  0,079  NAT2 substrate
0,053  0,042  Alcohol oxidase inhibitor
0,066  0,055  Anticholelithogenic
0,072  0,062  GABA B receptor agonist
0,060  0,051  Prolactin release inhibitor
0,096  0,088  Antifungal (Aspergillus)
0,056  0,047  Androgen agonist
0,088  0,082  GABA C receptor agonist
0,093  0,088  Mucolytic
0,117  0,112  Farnesoid X receptor antagonist
0,095  0,090  GST T1-1 substrate
0,022  0,018  Dopamine D1 agonist
0,031  0,027  Glutamate (mGluR3) agonist
0,105  0,101  Antiprotozoal (Amoeba)
0,166  0,163  Antineoplastic (pancreatic cancer)
0,102  0,100  Transcription factor STAT6 inhibitor
0,029  0,029  Catechol O-methyltransferase inhibitor
0,066  0,065  CYP2A6 inhibitor

